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Epilepsy is the fourth most common disorder that affects the nervous 
system, with only migraine, cerebrovascular incidents and Alzheimer’s 
disease being more common. Epilepsy affects ~50 million people 
worldwide.[1] In Africa, epilepsy affects ~10 million people.[2] Global 
statistics show that about one-third of patients with epilepsy are refrac-
tory to anti-epileptic medication.[3] This translates into ~2.5 million 
people in Africa with devastating epilepsy, who may require alternative 
treatment to control or cure their epilepsy. 
Since 1886, neurosurgeons such as Horsley, Penfield and Krause 
have been interested in the surgical treatment of epilepsy in both 
adults and children.[4] From these early days, doctors understood that 
epilepsy is caused by abnormal electrical discharges in a specific part 
of the brain. This led to the premise that if that abnormal part of the 
brain can be resected, the epilepsy will be controlled.
Indications for surgery
Surgery should be the main therapeutic option in refractory epilepsy 
if a clear cause has been identified. This is the case in patients with 
focal cortical developmental or migrational abnormalities, and in 
patients in whom epilepsy is associated with a tumour or lesion in 
the brain. Undertaking surgery is a much more difficult decision in 
patients with cryptogenic epilepsy, i.e. where there is no anatomical 
abnormality demonstrable on a magnetic resonance imaging (MRI) 
scan. At this point, the role of the functional neurosurgeon specialising 
in epilepsy surgery and working in conjunction with an experienced 
epileptologist (neurologist with a special interest in epilepsy) becomes 
vital. Surgery for epilepsy is never an emergency, except in rare cases 
of rapidly enlarging brain tumours, but then the focus is on tumour 
surgery and not treating the epilepsy. The timing of surgery in the 
course of the disease also needs some consideration, with the benefit 
of earlier surgery becoming more evident from recent data. It has been 
demonstrated that earlier control of seizures (at a younger age) leads to 
better long-term outcomes in patients with epilepsy.[5,6] 
For a patient with epilepsy to be considered for work-up for surgery, 
the following criteria must be met:
• The patient must be refractory to medical treatment, i.e. the 
patient must be on adequate medical therapy with at least two 
drugs, one of which is a newer-generation agent that is monitored 
and prescribed by an experienced epileptologist, and have life-
impairing seizures.[7] There is no time duration to this definition.
• There must be correlation shown between semiology (clinical 
presentation, e.g. posturing, during an attack), anatomy (imaging 
findings on an MRI scan) and electrical (findings on an electro-
encephalogram (EEG) tracing) abnormalities.
Work-up for surgery
The work-up in a patient with epilepsy, who is a potential candidate 
for surgery, requires a multidisciplinary approach. Patients with 
significant epilepsy are usually managed by an epileptologist (a 
paediatric neurologist, or an adult neurologist with a special interest 
and experience in treating patients with epilepsy). The team must be 
convinced that the patient is on optimal medication to prove refracto-
riness before surgery is considered. Pre-operative neuropsychological 
testing can help in determining the side of dominance of speech and 
memory and the psychological impairment, and prepare the family 
for significant changes if the surgery is successful. It seems odd to be 
concerned about this, but for a family with a patient with a chronic 
illness such as epilepsy, the patient not having epilepsy often leads to 
greater anxiety and is a challenge. Therefore, meticulous psychologi-
cal follow-up and preparation are of the utmost importance. The neu-
rosurgeon takes part in the counselling and evaluation of the patient 
and the interpretation of the multimodality imaging and telemetry to 
plan the surgery. 
Careful telemetry is needed, while the patient is kept in a unit 
with constant 24-hour per day video surveillance and is connected 
to the EEG monitor for the entire period, sometimes for a few days. 
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The fact that epilepsy can be cured or ameliorated with surgery is an often neglected and overlooked aspect of modern management. 
Epilepsy affects almost 50 million people worldwide. One-third of people who suffer from epilepsy are refractory to medication alone. It 
is this group of patients who may benefit from epilepsy surgery, which can be divided into three main categories, i.e. resection procedures, 
disconnection procedures, and neuromodulation procedures. The goal of surgery in epilepsy is to remove the epileptogenic region from the 
brain, or to disconnect it and thereby prevent spread to other parts of the brain. In cases where this is not possible owing to the location of 
the epileptic focus, certain neuromodulation techniques may benefit the patient. Successful outcomes of epilepsy surgery techniques vary 
from 50% to 80% in rendering patients free of their epilepsy; many more patients can expect improvement in the severity or frequency of 
their disabling seizures. The outcome depends on factors such as age, location of the epileptogenic zone, histology and cause of the seizures. 
Patients undergo a detailed and prolonged work-up to determine candidacy and to decide on the safest technique that will lead to the best 
outcomes. An experienced team should perform the surgery. This team should consist of multiple members who can attend to the medical, 
social, psychological and reintegration needs of the patient before and after surgery.
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This allows accurate correlation between the ictus (seizure event), 
clinical presentation (semiology) and EEG of the patient during the 
event. The patient undergoes neuro-imaging to illustrate the corti-
cal abnormality that may be associated with the epileptiform area. 
Currently, 3 Tesla MRI scanning is becoming the gold standard for 
the imaging of patients with epilepsy, as it allows the epilepsy surgery 
team to evaluate for subtle cortical abnormalities that were previously 
left undetected by 1.5 Tesla scanners. Special sequencing, such as 
diffusion tractography imaging and functional MRI, can be used to 
determine the association between eloquent brain areas and the epi-
leptogenic area, thereby allowing preservation of function in patients 
who undergo resection of the epileptiform area. Some epilepsy sur-
gery units have access to positron emission tomography (PET) scan-
ning that allows visualisation of abnormal activity or active lesions in 
cases of multiple lesions, e.g. patients with tuberous sclerosis, hereby 
determining which lesion is responsible for the seizures. Combining 
pre-ictal and ictal single-photon emission computed tomography 
(SPECT) scans can also be very helpful in localising the epileptiform 
cortex, especially in patients in whom there is no structural abnor-
mality detectable on MRI. The intracarotid injection of amobarbital 
(Wada test) has mostly been replaced by functional MRI, which 
offers a non-invasive way to determine lateralisation of functions 
such as speech and memory. This is especially important in temporal 
lobectomies. A CT scan has limited use in the work-up of refractory 
epilepsy, but is often still the first imaging modality employed owing 
to the cost associated with MRI scanning.
Surgical procedures   
The goal of surgery is always maximal resection of the epileptiform 
focus, tempered by the need to respect and preserve functional 
areas, venous drainage, arterial supply and white matter connecting 
tracts. 
Surgery for epilepsy is divided into three major categories:
• anatomical resection procedures, e.g. resection of the frontal lobe 
or temporal lobe
• disconnection procedures (disconnecting the epileptiform cortex 
from the rest of the brain by sectioning white matter tracts)
• neuromodulation (placing of vagal nerve stimulator or deep brain 
stimulation for epilepsy).
Resection techniques
The choice of resection techniques, or combinations thereof, depends 
on the location of the epileptiform focus, eloquent tissue, vascular 
supply, and venous drainage patterns. Surgical planning is also 
informed by only grey matter (cerebral cortex) having epileptogenic 
potential; however, seizure activity can propagate via white matter 
tracts. Resective techniques remove the offending area or lesion, 
often also with a subcortical bank of tissue, whereas disconnective 
techniques tend to leave the area of epileptogenic grey matter as an 
isolated island in the brain.
Certain types of epilepsy are better controlled with specific tech-
niques, e.g. atonic seizures (drop attacks) are ideal cases for cor pus 
callosotomy, as this prevents generalisation to the contralateral 
cortex. Patients continue to have unilateral seizure activity, but not 
the dangerous atonic seizure that often leads to falling into a fire or 
in front of a moving vehicle. In eloquent areas the surgeon uses a 
subpial dissection technique, where the pial bank is preserved against 
blood vessels and nerves, while the grey matter is dissected out and 
away from the white matter tracts, often using an ultrasonic aspirat-
ing device on very low suction and fractionation settings. An area of 
white matter network, which is free of the electrically active grey mat-
ter, is left behind. Electrical mapping techniques are used during the 
procedure to preserve eloquent brain matter. In this way the delicate 
border between eloquent tissue and epileptiform tissue is delineated, 
allowing safe resection. 
It is important to stress the difference between tumour surgery 
and epilepsy surgery. In tumour surgery the focus is on removing 
the lesion and the malignant infiltrates in the surrounding tissue, 
which are often not visible under a microscope. Various techniques 
are used to allow visualisation of this infiltrated area, e.g. amino-acid 
PET masking. Traditionally, this approach is used in epilepsy surgery 
associated with lesions, such as developmental neuro-ectodermal 
tumours. The belief is that the lesion is epileptogenic; therefore, per-
forming a lesionectomy is all that is required to control the seizures. 
However, epilepsy surgeons are aware that, in some cases, this does 
not control the epilepsy (Figs 1 and 2 illustrate this principle). Part 
of the work-up for epilepsy surgery takes this into account and great 
effort is made to search for the epileptiform cortex, even more distant 
from the lesion. This is why in epilepsy surgery the term topectomy is 
preferred rather than lesionectomy. 
Disconnection techniques
In patients in whom the focus of the epileptiform activity is restricted 
to an area that does not allow resection owing to its eloquence, 
another approach is to ‘disconnect’ that part of the brain from the 
rest, thereby in effect isolating the epileptic activity to a focal portion 
of the brain and preventing secondary generalisation. An example of 
this is a functional hemispherectomy, where the diseased hemisphere 
is disconnected from the rest of the brain and the patient does not 
have dangerous progression of focal seizures to generalised seizures. 
This procedure is a variation of the older technique of anatomical 
hemispherectomy, where one half of the brain was removed. This led 
to significant morbidity and mortality. 
Epileptogenic zone
Resection to control
seizures
Lesion
Fig. 1. Relationship between lesion and resection margins that may be 
required to control seizures.
Tumour/
lesion
Epileptogenic zone
Fig. 2. Resecting of a lesion may not always cure epilepsy.
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Neuromodulation techniques
Neuromodulation for epilepsy is being investigated, as it is seen as the 
next great frontier in epilepsy surgery. In the same manner that deep brain 
stimulation has been shown to have a significant effect in patients with 
Parkinson’s disease, dystonia and tremor, certain targets in the thalamus 
show promise in treating medication- and surgery-refractory epilepsy. 
Vagal nerve stimulation is a surgical procedure in which a small wrap-
around electrode is placed on the left vagal nerve in its cervical course. This 
electrode is then connected to an implanted pulse generator, similar to a 
cardiac pacemaker, which stimulates the vagal nerve at a predetermined 
frequency and amplitude. The mechanism of action is as yet unsure, but 
it does show at least a 50% improvement in 50% of patients who have the 
device implanted.[5] It seems as though only a small number of patients 
benefit, but it is important to remember that this group of patients suffer 
tremendously and that medication and other surgical options have failed 
or are not possible. Therefore, even such small odds are worthwhile 
and can lead to great improvement in quality of life. Some of the more 
recent trials are related to deep brain stimulation (DBS) for drug-resistant 
epilepsy.[8] In this procedure a DBS electrode is placed into the anterior 
nucleus of the thalamus via a stereotactic technique and an implanted 
pulse generator produces a constant pulse at a predetermined frequency, 
which modulates abnormal electrical activity in the brain. More recently, 
promising work has been done, where a subdural or depth electrode and 
a thalamic electrode are implanted into the epileptic zone in the brain. As 
soon as abnormal electrical activity is detected in a closed loop system, 
the pulse generator stimulates the thalamus and the abnormal electrical 
activity is aborted.[9] This technique is still in its infancy as a treatment for 
medical refractory epilepsy, but holds great potential, especially for non-
lesional epilepsy or epilepsy with seizure foci that are in non-resectable 
areas. 
Surgical risks for epilepsy
Surgery for epilepsy is a major decision and there are significant asso-
ciated risks. Therefore, strict criteria need to be met before surgery 
can be considered in the treatment of medical refractory epilepsy. 
Surgery can lead to memory impairment after temporal lobectomies, 
and motor weakness or aphasia in hemispheric procedures. Occipital 
lobe surgery and damage to the optic tract in medial temporal 
lobe resections can lead to blindness. Disturbances in the flow of 
cerebrospinal fluid can lead to hydrocephalus that will require shunt 
procedures, with associated risks.
These risk factors need to be weighed up against those associated 
with the long-term use of anti-epileptic medication. Females, espe-
cially, have to consider the teratogenic effect of most first-line anti-
epileptic medication during pregnancy. Untreated epilepsy carries 
significant morbidity and even mortality. Sudden unexpected death 
in epilepsy is a rare, but real threat to patients with the condition. 
There are therefore certain conditions, such as focal cortical dys-
plasia and dysembryoplastic neuro-epithelial tumours, which are 
known to be mostly refractory to anti-epileptic drugs, where an 
argument can be made to perform the respective surgery as soon as 
a diagnosis is made, especially if the lesion is in a non-eloquent area, 
such as the medial temporal lobe in the right hemisphere. 
Outcomes of epilepsy surgery
In the follow-up of patients after epilepsy surgery it is important 
to enquire about seizures and their frequency. For many years the 
emphasis of epilepsy surgery outcomes has focused on these aspects, 
but increasingly units are publishing their data on patients with 
regard to their memory, school performance, and psychological and 
emotional wellbeing.[10] Fewer seizures is only half of the problem 
solved, as 45 - 50%[10] of patients suffer from depression and anxiety 
after surgery and careful evaluation is needed to determine sequelae 
of the resected cortical tissue and its effect on mood, memory and 
personality, with school and work performance being sensitive 
surrogates to evaluate this. In the absence of seizures, patients 
have difficulty in dealing with these new feelings of depression and 
emotional lability. The treating team need to be aware of this and pre-
empt these factors during counselling. 
Freedom of seizures after surgery is the primary goal, though. 
The outcome is dependent on the aetiology of the seizure, location 
of the epileptiform region, degree of resection done and type of 
procedure performed. Some published epilepsy surgery outcomes 
are summarised in Table 1.[11-13] There are some factors that have 
been identified to yield better long-term seizure freedom after 
surgery,  e.g. presence of hippocampal atrophy and absence of 
generalised tonic-clonic seizures. Spencer et al.[14] found that 25% of 
patients relapse after 2 years of seizure freedom in cases of temporal 
lobe resections. Patients with medial temporal lobe epilepsy, who 
are operated on later in life, also show a worse seizure freedom rate 
after surgery.[15] This is yet another motivation for earlier surgery in 
patients who are medically refractory to epilepsy treatment. 
Children with epilepsy and a specific lesion on MRI are also 
increasingly free of seizures after surgery compared with those with no 
identifiable lesion – only an electrically localisable focus (70% v. 56% in 
a temporal focus). The seizure freedom rate in non-lesional epilepsy is 
about 62%, independent of the presence of a lesion.[16] In a study by the 
University of California, Los Angeles (UCLA) group[17] it was shown 
that children with cortical dysplasia have a slightly higher recurrence 
rate than other patients with epilepsy, but it is clear that early surgery, 
before 3 years of age, makes a significant difference and leads to lower 
seizure recurrence rates. In a comparison of children with cortical dys-
plasia and surgery before 3 years of age v. older children, the younger 
group showed 65% seizure freedom compared with 38% in the older 
group at 5 years after epilepsy surgery follow-up.[17] 
Even though more than half of patients remain seizure free after 
surgery, the trend in our unit and most of the rest of the world is to 
taper the anti-epileptic medication slowly 6 months after surgery. 
Most patients (95%) who are seizure free at 6 months after surgery 
remain seizure free thereafter.[18]
Table 2 summarises possible causes of seizure recurrence after suc-
cessful surgery.[19,20] Careful multidisciplinary follow-up and counsel-
Table 1. Summary of epilepsy surgery outcomes[11-13]
Adults Temporal epilepsy Extratemporal epilepsy Extratemporal lesion Frontal seizures
Seizure free after 1 year, % 68 45 67 23
Significant improvement, % 24 35 23 32
Seizure free at 1 year Temporal epilepsy Extratemporal epilepsy Hemispherectomy All surgeries
Children, % 74 58 67 67
Adolescents, % 80 52 75 69
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ling is an ongoing process and the patient is 
never completely discharged – support and 
motivation continue life-long.
Summary
Surgery for medical refractory epilepsy 
requires a multidisciplinary approach that 
involves neurosurgeons, epileptologists, 
neuropsy chologists and a keen team of nurs-
ing and social worker staff. With the premise 
that about 2.5 million people in Africa have 
medically refractory epilepsy that may be 
treated with surgery, a great deal of aware-
ness needs to be spread among physicians, 
nursing personnel and families of patients 
with severe epilepsy. Early surgery in patients 
with localisable seizure foci in non-eloquent 
areas such as the medial temporal lobe leads 
to significant reductions (>70%) in epilepsy. 
Epilepsy is one of the most disabling 
chronic diseases; if help is possible, it must 
be made available to those who need it. With 
the increasing amount of knowledge, imaging 
methods and surgical techniques gained every 
year, surgery for epilepsy can be done safely 
and produce reliable results. Ultimately, the 
quality of life of patients with this devastating 
disease can be greatly improved. Timely 
referral to specialist epilepsy surgery units is 
mandatory if we want to decrease this disease 
burden on patients and their families.  
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